Clinical Trial Update: Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of irbesartan, ciprofibrate, and their combination on endothelial function in patients with hypertension and dyslipidemia ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Drugs mentioned

• Ciprofibrate (ciprofibrate)
• Irbesartan (irbesartan)

Snippet

Sponsor: Sanofi | Conditions: Hypertension, Dyslipidemia | Phase 4 | Status: COMPLETED